Skip to content

US · POCI · MEDICAL - INSTRUMENTS & SUPPLIES

Precision Optics Corporation, Inc. (POCI) intrinsic value and stock valuation

$4.12as of 2026-11-21 · Mkt cap 47.06M

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Precision Optics Corporation, Inc. DCF and intrinsic value

InvestorsCraft values POCI with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from POCI’s statements →

Precision Optics Corporation, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Instruments & Supplies Gardner, MA 01440 poci.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$19.1M+14% 5y CAGRd
20112025
Net income
-$-5.78M
20112025
Free cash flow
-$-3.77M
20112025
Total equity
$12.3M+34.6% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$19.1M$19.1M$21M$15.7M$10.7M
Operating income-$-5.55M-$-2.72M-$-640K-$-1.35M-$-910K
Net income-$-5.78M-$-2.95M-$-140K-$-930K-$-100K
EPSd-$-851.25K-$-486K-$-24.69K-$-175.47K-$-22.57K
Operating cash flow-$-3.55M-$-2.68M-$-80K-$-930K$50K
Capital expenditure-$-230K-$-290K-$-50K-$-150K-$-120K
Free cash flow-$-3.77M-$-2.98M-$-130K-$-1.09M-$-80K
Total assets$19.8M$16.9M$19.7M$16.7M$6.26M
Total debt$2.04M$3.43M$3.16M$3M$250K
Net debt$260K$3.03M$230K$2.39M-$-610K
Total equity$12.3M$10.1M$12.1M$8.97M$3.43M
Cash and short-term investments$1.77M$410K$2.93M$610K$860K
Income statement
20252024202320222021
Revenue$19.1M$19.1M$21M$15.7M$10.7M
Cost of revenue$15.7M$13.3M$13.3M$10.8M$7.24M
Gross profit$3.4M$5.8M$7.73M$4.93M$3.43M
Research and development expenses$1.16M$980K$990K$670K$620K
Selling, general and administrative expenses$7.8M$7.54M$7.38M$5.61M$3.71M
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$8.96M$8.52M$8.37M$6.28M$4.34M
Cost and expenses$24.6M$21.8M$21.7M$17.2M$11.6M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$230K$230K$220K$160K$10K
Depreciation and amortization$210K$210K$210K$250K$150K
Ebitda-$-5.34M-$-2.51M$290K-$-530K$50K
Operating income-$-5.55M-$-2.72M-$-640K-$-1.35M-$-910K
Total other income/expenses, net-$-230K-$-230K$500K$590K$800K
Income before tax-$-5.78M-$-2.95M-$-140K-$-930K-$-100K
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-5.78M-$-2.95M-$-140K-$-930K-$-100K
Weighted average shares outstanding$6.79M$6.07M$5.67M$5.3M$4.43M
Weighted average diluted shares outstanding$6.79M$6.07M$5.67M$5.3M$4.43M
Balance sheet
20252024202320222021
Cash and short-term investments$1.77M$410K$2.93M$610K$860K
Net receivables$4.34M$3.55M$3.91M$2.66M$1.88M
Inventory$3.56M$2.87M$2.78M$3.02M$1.89M
Total current assets$10.1M$7.12M$9.86M$6.51M$4.78M
Property, plant and equipment, net$680K$680K$790K$1.15M$660K
Goodwill and intangible assets$9.06M$9.11M$9.09M$9.05M$830K
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$9.73M$9.79M$9.88M$10.2M$1.48M
Total assets$19.8M$16.9M$19.7M$16.7M$6.26M
Accounts payable$2.91M$1.4M$2.43M$2.24M$1.21M
Short-term debt$660K$1.5M$730K$560K$200K
Deferred revenue$1.82M$1.17M$1.17M$910K$450K
Total current liabilities$6.15M$4.91M$5.26M$4.59M$2.51M
Long-term debt$1.38M$1.94M$2.43M$2.44M$150K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$1.38M$1.94M$2.43M$3.15M$320K
Capital lease obligations$170K$260K$470K$670K$250K
Total liabilities$7.53M$6.84M$7.69M$7.73M$2.83M
Common stock$80K$60K$60K$170K$130K
Retained earnings-$-56.97M-$-51.19M-$-48.24M-$-48.09M-$-47.17M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$12.3M$10.1M$12.1M$8.97M$3.43M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$2.04M$3.43M$3.16M$3M$250K
Net debt$260K$3.03M$230K$2.39M-$-610K
Cash flow statement
20252024202320222021
Net income-$-5.78M-$-2.95M-$-140K-$-930K-$-100K
Depreciation and amortization$210K$210K$210K$190K$150K
Stock-based compensation$1.46M$960K$920K$920K$730K
Change in working capital$510K-$-920K-$-360K-$-420K$70K
Accounts receivable-$-790K$360K-$-1.24M-$-110K-$-400K
Inventory-$-690K-$-90K$250K-$-680K$310K
Accounts payable$1.51M-$-1.03M$190K$820K$140K
Net cash provided by operating activities-$-3.55M-$-2.68M-$-80K-$-930K$50K
Investments in property, plant and equipment-$-230K-$-270K-$-50K-$-150K-$-120K
Acquisitions, net$0.00$0.00$0.00-$-260K-$-170K
Net cash used for investing activities-$-230K-$-290K-$-50K-$-410K-$-290K
Common stock issued$6.36M$10K$2.29M$1.5M$30K
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$5.15M$460K$2.45M$1.09M-$-30K
Net change in cash$1.37M-$-2.52M$2.32M-$-260K-$-270K
Cash at end of period$1.77M$410K$2.93M$610K$860K
Operating cash flow-$-3.55M-$-2.68M-$-80K-$-930K$50K
Capital expenditure-$-230K-$-290K-$-50K-$-150K-$-120K
Free cash flow-$-3.77M-$-2.98M-$-130K-$-1.09M-$-80K
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Precision Optics Corporation, Inc.

        Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature medical cameras, and cutting-edge 3D endoscopes, all designed for application in minimally invasive surgical procedures carried out by hospitals and healthcare professionals. Beyond its medical division, POCI also produces individual parts and integrated assemblies for industrial and military purposes. POCI markets its medical device portfolio primarily to other corporations within the medical technology sector. Established in 1982, the firm's headquarters are located in Gardner, Massachusetts.

        CEO
        Joseph N. Forkey
        Employees
        90
        Beta
        0.32

        Explore

        Frequently asked questions

        What is the intrinsic value of Precision Optics Corporation, Inc. (POCI)?

        Precision Optics Corporation, Inc. (POCI) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is POCI undervalued?

        POCI trades at a price of $4.12 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.